HORNER PHARMACY LIMITED

Company Registration Number:
NI056317 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

HORNER PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

HORNER PHARMACY LIMITED

Balance sheet

As at 31 March 2025


Notes

2025

2024


£

£
Fixed assets
Tangible assets: 3 230,716 253,580
Total fixed assets: 230,716 253,580
Current assets
Stocks: 286,158 275,153
Debtors: 4 293,051 248,894
Cash at bank and in hand: 189,265 266,828
Total current assets: 768,474 790,875
Creditors: amounts falling due within one year: 5 (400,926) (391,420)
Net current assets (liabilities): 367,548 399,455
Total assets less current liabilities: 598,264 653,035
Creditors: amounts falling due after more than one year: 6 (53,475) (251,249)
Provision for liabilities: (35,129) (42,247)
Total net assets (liabilities): 509,660 359,539
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 509,560 359,439
Shareholders funds: 509,660 359,539

The notes form part of these financial statements

HORNER PHARMACY LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 21 July 2025
and signed on behalf of the board by:

Name: Mr John Horner
Status: Director

The notes form part of these financial statements

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 29 30

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 1,055,839
Additions 36,722
At 31 March 2025 1,092,561
Depreciation
At 01 April 2024 802,259
Charge for year 59,586
At 31 March 2025 861,845
Net book value
At 31 March 2025 230,716
At 31 March 2024 253,580

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Debtors

2025 2024
££
Debtors due after more than one year: 293,051 248,894

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

5. Creditors: amounts falling due within one year note

Trade creditors - £234,432 Accruals - £12,190 Corporation Tax - £57,864 Obligations under finance lease - £27,900 Directors' loan - £68,540

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

6. Creditors: amounts falling due after more than one year note

Obligations under finance leases - £53,475

HORNER PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

7. Related party transactions

Name of the related party:
Relationship:
Directors
Description of the Transaction: The company owed the directors
£
Balance at 01 April 2024 249,874
Balance at 31 March 2025 68,540

The company occupies premises owned by the director Mr John Horner to whom a commercial rent of £40,000 is payable annually.